<!DOCTYPE html>
<!--[if (gt IE 9)|!(IE)]> <!--> <html lang="en" class="no-js has-comments blog-dealbook section-business"  itemscope xmlns:og="//opengraphprotocol.org/schema/"> <!--<![endif]-->
<!--[if IE 9]> <html lang="en" class="no-js ie9 lt-ie10 has-comments blog-dealbook section-business" xmlns:og="//opengraphprotocol.org/schema/"> <![endif]-->
<!--[if IE 8]> <html lang="en" class="no-js ie8 lt-ie10 lt-ie9 has-comments blog-dealbook section-business" xmlns:og="//opengraphprotocol.org/schema/"> <![endif]-->
<!--[if (lt IE 8)]> <html lang="en" class="no-js lt-ie10 lt-ie9 lt-ie8 has-comments blog-dealbook section-business" xmlns:og="//opengraphprotocol.org/schema/"> <![endif]-->
<head>
	<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function(e,n,t){function r(t){if(!n[t]){var o=n[t]={exports:{}};e[t][0].call(o.exports,function(n){var o=e[t][1][n];return r(o||n)},o,o.exports)}return n[t].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<t.length;o++)r(t[o]);return r}({1:[function(e,n,t){function r(){}function o(e,n,t){return function(){return i(e,[c.now()].concat(u(arguments)),n?null:this,t),n?void 0:this}}var i=e("handle"),a=e(2),u=e(3),f=e("ee").get("tracer"),c=e("loader"),s=NREUM;"undefined"==typeof window.newrelic&&(newrelic=s);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],d="api-",l=d+"ixn-";a(p,function(e,n){s[n]=o(d+n,!0,"api")}),s.addPageAction=o(d+"addPageAction",!0),s.setCurrentRouteName=o(d+"routeName",!0),n.exports=newrelic,s.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(e,n){var t={},r=this,o="function"==typeof n;return i(l+"tracer",[c.now(),e,t],r),function(){if(f.emit((o?"":"no-")+"fn-start",[c.now(),r,o],t),o)try{return n.apply(this,arguments)}finally{f.emit("fn-end",[c.now()],t)}}}};a("setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(e,n){m[n]=o(l+n)}),newrelic.noticeError=function(e){"string"==typeof e&&(e=new Error(e)),i("err",[e,c.now()])}},{}],2:[function(e,n,t){function r(e,n){var t=[],r="",i=0;for(r in e)o.call(e,r)&&(t[i]=n(r,e[r]),i+=1);return t}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],3:[function(e,n,t){function r(e,n,t){n||(n=0),"undefined"==typeof t&&(t=e?e.length:0);for(var r=-1,o=t-n||0,i=Array(o<0?0:o);++r<o;)i[r]=e[n+r];return i}n.exports=r},{}],4:[function(e,n,t){n.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(e,n,t){function r(){}function o(e){function n(e){return e&&e instanceof r?e:e?f(e,u,i):i()}function t(t,r,o,i){if(!d.aborted||i){e&&e(t,r,o);for(var a=n(o),u=m(t),f=u.length,c=0;c<f;c++)u[c].apply(a,r);var p=s[y[t]];return p&&p.push([b,t,r,a]),a}}function l(e,n){v[e]=m(e).concat(n)}function m(e){return v[e]||[]}function w(e){return p[e]=p[e]||o(t)}function g(e,n){c(e,function(e,t){n=n||"feature",y[t]=n,n in s||(s[n]=[])})}var v={},y={},b={on:l,emit:t,get:w,listeners:m,context:n,buffer:g,abort:a,aborted:!1};return b}function i(){return new r}function a(){(s.api||s.feature)&&(d.aborted=!0,s=d.backlog={})}var u="nr@context",f=e("gos"),c=e(2),s={},p={},d=n.exports=o();d.backlog=s},{}],gos:[function(e,n,t){function r(e,n,t){if(o.call(e,n))return e[n];var r=t();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,n,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return e[n]=r,r}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],handle:[function(e,n,t){function r(e,n,t,r){o.buffer([e],r),o.emit(e,n,t)}var o=e("ee").get("handle");n.exports=r,r.ee=o},{}],id:[function(e,n,t){function r(e){var n=typeof e;return!e||"object"!==n&&"function"!==n?-1:e===window?0:a(e,i,function(){return o++})}var o=1,i="nr@id",a=e("gos");n.exports=r},{}],loader:[function(e,n,t){function r(){if(!x++){var e=h.info=NREUM.info,n=d.getElementsByTagName("script")[0];if(setTimeout(s.abort,3e4),!(e&&e.licenseKey&&e.applicationID&&n))return s.abort();c(y,function(n,t){e[n]||(e[n]=t)}),f("mark",["onload",a()+h.offset],null,"api");var t=d.createElement("script");t.src="https://"+e.agent,n.parentNode.insertBefore(t,n)}}function o(){"complete"===d.readyState&&i()}function i(){f("mark",["domContent",a()+h.offset],null,"api")}function a(){return E.exists&&performance.now?Math.round(performance.now()):(u=Math.max((new Date).getTime(),u))-h.offset}var u=(new Date).getTime(),f=e("handle"),c=e(2),s=e("ee"),p=window,d=p.document,l="addEventListener",m="attachEvent",w=p.XMLHttpRequest,g=w&&w.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:w,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var v=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-1044.min.js"},b=w&&g&&g[l]&&!/CriOS/.test(navigator.userAgent),h=n.exports={offset:u,now:a,origin:v,features:{},xhrWrappable:b};e(1),d[l]?(d[l]("DOMContentLoaded",i,!1),p[l]("load",r,!1)):(d[m]("onreadystatechange",o),p[m]("onload",r)),f("mark",["firstbyte",u],null,"api");var x=0,E=e(4)},{}]},{},["loader"]);</script>
		<meta name="communityAssetLabels" content="NYT_Blogs" />
<meta name="communityAssetTaxonomy" content="blogs/dealbook/New Details Suggest a Defense in SAC Case" />
<meta name="communityAssetURL" content="https://dealbook.nytimes.com/2013/02/03/new-details-suggest-a-defense-in-sac-case/" />
<meta name="PT" content="Blogs" />
<meta name="PST" content="Blog Post" />
<meta name="sourceApp" content="blogs" />
<meta itemprop="identifier" name="blogpostid" content="100000002041967"><meta name="author" content="Andrew Ross Sorkin and Peter Lattman" />
<meta name="CLMST" content="Andrew Ross Sorkin and Peter Lattman" />
<meta name="byl" content="Andrew Ross Sorkin and Peter Lattman" />
<meta name="GBLC" content="Financial Services;Hedge Funds;Legal/Regulatory">
<meta name="PUV" content="normal" />
<meta property="article:published_time" itemprop="datePublished" content="1359950413" />
<meta name="PUD" content="20130203" />
<meta name="pdate" content="20130203" />
<meta name="ptime" content="20130203230013" />
<meta name="utime" content="20130204214205" />
<meta property="article:modified_time" itemprop="dateModified" content="2013-02-04T21:42:05-05:00" />
<meta name="DISPLAYDATE" content="February 3, 2013" />
<meta name="dat" content="February 3, 2013" />
<meta itemprop="articleSection" property="article:section" content="Business Day" />
<meta name="CG" content="Business Day" />
<meta name="SCG" content="Dealbook" />
<meta name="BN" content="dealbook" />
<meta name="robots" content="noodp">
<meta name="per" content="Cohen, Steven A">
<meta name="des" content="Insider Trading">
<meta name="org" content="SAC Capital Advisors">
<meta property="article:tag" content="Cohen Steven A" />
<meta property="article:tag" content="Insider Trading" />
<meta property="article:tag" content="SAC Capital Advisors" />
<meta property="article:tag" content="Financial Services" />
<meta property="article:tag" content="Hedge Funds" />
<meta property="article:tag" content="Legal/Regulatory" />
<meta name="keywords" content="Cohen Steven A,Insider Trading,SAC Capital Advisors,Financial Services,Hedge Funds,Legal/Regulatory" />
<link rel="alternate" type="application/json+oembed" href="https://www.nytimes.com/svc/oembed/json/?url=https%3A%2F%2Fdealbook.nytimes.com%2F2013%2F02%2F03%2Fnew-details-suggest-a-defense-in-sac-case%2F" title="New Details Suggest a Defense in SAC Case" />
<meta name="description" content="Internal trading records also raise questions on whether the government will be able to build a case against Steven A. Cohen, the billionaire owner of the hedge fund." />
<meta name="hdl_p" content="New Details Suggest A Defense In SAC Case" />
<meta name="hdl" content="New Details Suggest a Defense in SAC Case" />
<meta property="og:title" content="New Details Suggest a Defense in SAC Case" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://dealbook.nytimes.com/2013/02/03/new-details-suggest-a-defense-in-sac-case/" />
<meta property="og:site_name" content="DealBook" />
<meta property="og:description" content="Internal trading records also raise questions on whether the government will be able to build a case against Steven A. Cohen, the billionaire owner of the hedge fund." />
<meta property="og:image" content="https://static01.nyt.com/images/blogs_v5/../icons/t_logo_291_black.png"/>
<meta name="thumbnail_150" content="https://static01.nyt.com/packages/images/icons/t_logo_300_black.png"/>
<meta name="twitter:card" value="summary"><meta name="twitter:title" content="New Details Suggest a Defense in SAC Case" />
<meta name="twitter:url" content="https://dealbook.nytimes.com/2013/02/03/new-details-suggest-a-defense-in-sac-case/" />
<meta name="twitter:description" content="Internal trading records also raise questions on whether the government will be able to build a case against Steven A. Cohen, the billionaire owner of the hedge fund." />
<meta name="twitter:image" content="https://static01.nyt.com/packages/images/icons/t_logo_300_black.png"/>
<meta itemprop="thumbnailUrl" content="https://static01.nyt.com/packages/images/icons/t_logo_300_black.png" name="thumbnail" />
<meta name="twitter:site" content="@dealbook">
<link rel='prev' title='2 Top Officers at Barclays to Step Down' href='https://dealbook.nytimes.com/2013/02/03/barclays-c-f-o-to-step-down/' />
<link rel='next' title='Citigroup Names Senior Banker in Europe' href='https://dealbook.nytimes.com/2013/02/04/citigroup-appoints-senior-banker-in-europe/' />
<link rel='canonical' href='https://dealbook.nytimes.com/2013/02/03/new-details-suggest-a-defense-in-sac-case/' />
<link rel='shortlink' href='//nyti.ms/UkXa9x' />
<link rel='https://github.com/WP-API/WP-API' href='https://dealbook.nytimes.com/json' />
<meta name="adxPage" content="blog.nytimes.com/dealbook/post" />
<link rel="alternate" type="application/rss+xml" title="RSS 2.0" href="https://dealbook.nytimes.com/feed/" />
<meta property="article:collection" content="https://static01.nyt.com/services/json/sectionfronts/business/index.jsonp" />
<link rel="alternate" href="//mobile.nytimes.comdealbook/2013/02/03/new-details-suggest-a-defense-in-sac-case/" />
<meta name="dfp-ad-unit-path" content="businessday/dealbook" />			<title>New Details Suggest a Defense in SAC Case - The New York Times</title>
            <!--[if (gt IE 9)|!(IE)]> <!-->
    <link rel="stylesheet" type="text/css" media="screen" href="https://int.nyt.com/assets/blogs/latest/css/blogs/styles.css" />
<!--<![endif]-->
<!--[if lte IE 9]>
    <link rel="stylesheet" type="text/css" media="screen" href="https://int.nyt.com/assets/blogs/latest/css/blogs/styles-ie.css" />
<![endif]-->
<link rel="stylesheet" type="text/css" media="screen" href="https://int.nyt.com/assets/blogs/latest/css/blogs/dealbook.css" />
<link rel="stylesheet" type="text/css" media="print" href="https://int.nyt.com/assets/blogs/latest/css/blogs/styles-print.css" />
<script>
var NYT = NYT || {}, NYTD = NYTD || {};
</script>
                        	<script src="https://int.nyt.com/assets/blogs/latest/js/blogs/layout.js"></script>
	<script type="text/javascript">var googletag=googletag||{};googletag.cmd=googletag.cmd||[],function(){var t=document.createElement("script");t.async=!0,t.type="text/javascript";var e="https:"==document.location.protocol;t.src=(e?"https:":"http:")+"//www.googletagservices.com/tag/js/gpt.js";var o=document.getElementsByTagName("script")[0];if (!/NYT-T=out/.test(document.cookie)) {o.parentNode.insertBefore(t,o)}}();</script>
<script id="magnum-feature-flags" type="application/json">["limitFabrikSave","facebookOauthButton","videoVHSCover","videoVHSShareTools","videoVHSEmbeddedOnly","removeInternationalEdition","piiBlockDFP","indexAsHeaderBidder","caslOpt"]</script>
<script>
var require = {
    baseUrl: 'https://int.nyt.com/assets/',
    waitSeconds: 20,
    paths: {
        'foundation': 'blogs/latest/js/foundation',
        'shared': 'blogs/latest/js/shared',
        'blogs': 'blogs/latest/js/blogs',
        'auth/mtr': 'https://static01.nyt.com/js/mtr',
        'auth/growl': 'https://static01.nyt.com/js/auth/growl/default',
        'vhs': 'https://static01.nyt.com/video/vhs/build/vhs-2.x.min'
    }
};
</script>
<!--[if (gte IE 9)|!(IE)]> <!-->
<script data-main="foundation/main" src="https://int.nyt.com/assets/blogs/latest/js/foundation/lib/framework.js"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
<script>
require.map = { '*': { 'foundation/main': 'foundation/legacy_main' } };
</script>
<script data-main="foundation/legacy_main" src="https://int.nyt.com/assets/blogs/latest/js/foundation/lib/framework.js"></script>
<![endif]-->
<script>
require(['foundation/main'], function () {
    require(['auth/mtr']);
});
</script>
<!--esi
<script id="user-info-data" type="application/json">
<esi:include src="/svc/web-products/userinfo-v3.json" />
</script>
-->
    	</head><body class="single single-post postid-550950 blog-universal nyt-blog-dealbook" id="" data-env="production" data-region="ewr1">
	<div id="shell" class="shell">
			<header id="masthead" class="masthead masthead-theme-standard" role="banner">
    <div class="container">
        <div class="quick-navigation button-group">
            <button class="button sections-button"><i class="icon sprite-icon"></i><span class="button-text">Sections</span></button>
            <button class="button home-button" data-href="https://www.nytimes.com/" title="Go to the home page to see the latest top stories."><i class="icon sprite-icon"></i>
                <span class="button-text">Home</span>
            </button>
            <button class="button search-button"><i class="icon sprite-icon"></i><span class="button-text">Search</span></button>
            <a class="button skip-button skip-to-content visually-hidden focusable" href="#main">Skip to content</a>
                                </div><!-- close button-group -->
        <div class="branding">
            <h2 class="branding-heading">
                <a id="branding-heading-link" href="https://www.nytimes.com/">
                    <span class="visually-hidden">The New York Times</span>
                </a>
            </h2>
            <script>window.magnum.writeLogo('small', 'https://int.nyt.com/assets/blogs/latest/images/foundation/logos/', 'Business Day', 'masthead-theme-standard', 'standard', 'branding-heading-link', 'blogs');</script>
        </div><!-- close branding -->
        <div class="story-meta">
    <h6 class="kicker">
        <span class="kicker-label">
			            <a href="https://dealbook.nytimes.com">
                DealBook            </a>
			        </span>

                <span class="pipe">|</span>
        New Details Suggest a Defense in SAC Case        
    </h6>
</div><!-- close story-meta -->


        <div class="user-tools">
            <div id="Bar1" class="ad bar1-ad nocontent robots-nocontent"></div>
            <div id="sharetools-masthead" class="sharetools theme-classic"
	 data-shares="email,facebook,twitter,show-all|More"
	 data-url="https://dealbook.nytimes.com/2013/02/03/new-details-suggest-a-defense-in-sac-case/"
	 data-title="New Details Suggest a Defense in SAC Case"
	 data-description="&lt;span class=&quot;excerpt-inner&quot;&gt;Internal trading records also raise questions on whether the government will be able to build a case against Steven A. Cohen, the billionaire owner of the hedge fund. &lt;/span&gt;&lt;a href=&quot;https://dealbook.nytimes.com/2013/02/03/new-details-suggest-a-defense-in-sac-case/&quot; class=&quot;more-link&quot;&gt;Read&nbsp;more...&lt;/a&gt;"
	data-publish-date="February 3, 2013 11:00 pm">
<div class="ad sharetools-inline-article-ad hidden"></div>
</div><!-- close shareTools -->
            <button class="button search-button"><i class="icon sprite-icon"></i><span class="button-text">Search</span></button>
            <div class="user-tools-button-group button-group">
                <button class="button subscribe-button hidden" data-href="https://www.nytimes.com/subscriptions/Multiproduct/lp3004.html?campaignId=4XUYF">Subscribe Now</button>
                <button class="button login-button login-modal-trigger hidden">Log In</button>
                <button class="button comments-button  button-masthead" data-skip-to-para-id="">
</button>
                                <button class="button notifications-button hidden"><i class="icon sprite-icon"></i><span class="button-text">0</span></button>
                <button class="button user-settings-button"><i class="icon sprite-icon"></i><span class="button-text">Settings</span></button>
            </div><!-- close user-tools-button-group -->
        </div><!-- close user-tools -->
    </div><!-- close container -->
    <div class="search-flyout-panel flyout-panel">
    <button class="button close-button" type="button"><i class="icon"></i><span class="visually-hidden">Close search</span></button>
    <nav class="search-form-control form-control layout-horizontal">
    <h2 class="visually-hidden">Site Search Navigation</h2>
    <form class="search-form" role="search">
        <div class="control">
            <div class="label-container visually-hidden">
                                <label for="search-input">Search NYTimes.com</label>
                            </div>
            <div class="field-container">
                                <input id="search-input" name="search-input" type="text" class="search-input text" autocomplete="off" placeholder="Search NYTimes.com" />
                
                <button type="button" class="button clear-button" tabindex="-1" aria-describedby="clear-search-input"><i class="icon"></i><span id="clear-search-input" class="visually-hidden">Clear this text input</span></button>
                <div class="auto-suggest" style="display: none;">
                    <ol></ol>
                </div>
                <button class="button submit-button" type="submit">Go</button>
            </div>
        </div><!-- close control -->
    </form>
</nav>


</div><!-- close flyout-panel -->
    <div id="notification-modals" class="notification-modals"></div>
</header>
					<nav id="ribbon" class="ribbon ribbon-start nocontent robots-nocontent" aria-hidden="true">
    <div class="nocontent robots-nocontent">
        <ol class="ribbon-menu">
            <li class="collection ribbon-loader">
                <div class="loader "><span class="visually-hidden">Loading...</span></div>
            </li>
        </ol>
        <div class="ribbon-navigation-container">
            <nav class="ribbon-navigation next">
                <span class="visually-hidden">See next articles</span>
                <div class="arrow arrow-right">
                    <div class="arrow-conceal"></div>
                </div>
            </nav>
            <nav class="ribbon-navigation previous">
                <span class="visually-hidden">See previous articles</span>
                <div class="arrow arrow-left">
                    <div class="arrow-conceal"></div>
                </div>
            </nav>
        </div>
    </div><!-- close nocontent -->
</nav>
						<nav id="navigation" class="navigation">
    <h2 class="visually-hidden">Site Navigation</h2>
</nav><!-- close navigation -->

<nav id="mobile-navigation" class="mobile-navigation hidden">
    <h2 class="visually-hidden">Site Mobile Navigation</h2>
</nav><!-- close mobile-navigation -->

    <div id="navigation-edge" class="navigation-edge"></div>
				<main id="main" class="main" role="main">
				<div id="TopAd" class="ad top-ad"></div>
				<div id="mobilebanner" class="ad mobilebanner"></div>
								<div id="story" class="story theme-main">
		<div id="dealbook" class="spanAC blog">
			<header id="blogs-masthead" class="wrap">
	<div class="ad sponsortile-ad hidden nocontent robots-nocontent">
		<div class="caption">Supported by</div>
		<div id="sponsortile" class="ad sponsortile-ad-creative"></div>
	</div>
		<div class="element1">
	<div id="logo" ><a href="https://dealbook.nytimes.com/?module=BlogMain&action=Click&region=Header&pgtype=Blogs&version=Blog Post&contentCollection=Business Day" title="Go to DealBook Home"><img src="https://static01.nyt.com/images/blogs_v5/dealbook/dealbook_post.png" alt="DealBook - A Financial News Service of The New York Times"/></a></div>    </div>
    <div class="element2">
    <div class="inlineSearchControl">
	<form method="get" id="searchform" action="https://dealbook.nytimes.com/">
		<input type="text" value="" name="s" id="s" class="text" placeholder="Search DealBook">
		<button type="submit" class="searchsubmit">Search</button>
	</form>
</div>	</div>
	<div class="clear"></div>
		<div id="topic-nav">
		<ul>
			<li class="first"><a href="https://dealbook.nytimes.com/category/main-topics/mergers-acquisitions/">Mergers &amp; Acquisitions</a></li>
			<li><a href="https://dealbook.nytimes.com/category/main-topics/investment-banking/">Investment Banking</a></li>
			<li><a href="https://dealbook.nytimes.com/category/main-topics/private-equity/">Private Equity</a></li>
			<li><a href="https://dealbook.nytimes.com/category/main-topics/hedge-funds/">Hedge Funds</a></li>
			<li><a href="https://dealbook.nytimes.com/category/main-topics/ipoofferings/">I.P.O./Offerings</a></li>
			<li><a href="https://dealbook.nytimes.com/category/main-topics/venture-capital/">Venture Capital</a></li>
			<li class="last"><a href="https://dealbook.nytimes.com/category/main-topics/legal/">Legal/Regulatory</a></li>
		</ul>
	</div>
		</header>
	<div class="a-column " id="a-col">
	<div id="content" class="hfeed">
	<article class="post-550950 post type-post status-publish hentry category-financial-services category-hedge-funds category-legal tag-cohen-steven-a tag-insider-trading tag-sac-capital-advisors per-cohen-steven-a des-insider-trading org-sac-capital-advisors" id="post-550950">
	<header class="postHeader">
				<div class="postKicker">
					</div>
				<h1 itemprop="headline" class="entry-title">New Details Suggest a Defense in SAC Case</h1>
		<div class="story-meta-footer">
			<address class="byline author vcard" itemprop="author creator" itemtype="//schema.org/Person">
				By Andrew Ross Sorkin and Peter Lattman			</address>
			<!-- date published --><time class="dateline " datetime="2013-02-04T04:00:13+00:00" itemprop="datePublished">February 3, 2013 11:00 pm</time>
			<!-- date updated --><span class="visually-hidden updated">February 3, 2013 11:00 pm</span><button class="button comments-button  theme-kicker" data-skip-to-para-id="">
</button>
		</div>
			</header>
		<div class="entry-content">
	<div class="w592"><img src="https://static01.nyt.com/images/2013/02/04/business/04SAC/04SAC-tmagArticle-v2.jpg" id="100000002041676" width="592" height="395" alt="As an inquiry proceeds, Steven A. Cohen of SAC has not been accused of any wrongdoing." /><span class="credit">Steve Marcus/Reuters</span><span class="caption">As an inquiry proceeds, Steven A. Cohen of SAC has not been accused of any wrongdoing.</span></div>
<p class="story-body-text" itemprop="articleBody">At the center of the governmentâs insider trading case against a former portfolio manager at the hedge fund SAC Capital Advisors is a trade that directly involves Steven A. Cohen, the billionaire owner of the fund.</p>
<p class="story-body-text" itemprop="articleBody">New details about the case have emerged that could cast doubt on the way that trade has been portrayed by the authorities, suggesting a possible line of defense for the portfolio manager and raising questions about whether the government will be able to build a case against Mr. Cohen, who has long been in the cross hairs of an investigation for insider trading on Wall Street.</p>
<p class="story-body-text" itemprop="articleBody">Federal prosecutors have claimed that SAC dumped millions of shares of two pharmaceutical companies in 2008 after the former employee, Mathew Martoma, received secret information from a doctor about problems with a new Alzheimerâs drug.</p>

<p class="story-body-text" itemprop="articleBody"> In bringing its charges, the government said that SAC not only sold out of its position, but also bet against â or shorted â the drug companiesâ stocks before the public announcement of the bad news. The SAC short position, according to prosecutors, allowed it to earn big profits after shares of the companies, <a href="//dealbook.on.nytimes.com/public/overview?symbol=ELN&#038;inline=nyt-org" class="tickerized" title="More information about Elan Corporation PLC">Elan</a> and Wyeth, plummeted.</p>
<p class="story-body-text" itemprop="articleBody">âThe fund didnât merely avoid losses, it greedily schemed to profit further by shorting Elan and Wyeth stock,â said April Brooks, a senior <a href="//topics.nytimes.com/top/reference/timestopics/organizations/f/federal_bureau_of_investigation/index.html?inline=nyt-org" class="tickerized" title="More articles about the Federal Bureau of Investigation.">F.B.I.</a> official in New York, during a press conference on Nov. 20, the day Mr. Martoma was arrested.</p>
<div class="w190 right">
<h3 style="height: 17px; background: #346F9A; color: white; font-family: arial, helvetica, sans-serif; font-size: 11px !important; font-weight: bold; margin: 0 0 8px !important; padding: 3px 0 0 7px !important; text-transform: none !important;">Hedge Fund Inquiry</h3>
<p class="story-body-text" itemprop="articleBody"><script type="text/javascript" src="https://static01.nyt.com/packages/js/multimedia/bundles/SlidingBColGallery.js"></script><script language="javascript" type="text/javascript" src="https://static01.nyt.com/packages/js/multimedia/data/SlidingGallery/20121206_insider_SlidingGalleryBColPromo190.js"></script>
<link type="text/css" rel="stylesheet" href="https://static01.nyt.com/packages/css/multimedia/bundles/SlidingBColGallery.css" />
<div id="NYTMM_Embed567"></div>
<p class="story-body-text" itemprop="articleBody"><script> var _obj = new NYTMM.SlidingBColGallery($("NYTMM_Embed567"),190,126,chameleonData); _obj.setFixedHeight(250); _obj.setPhotoData(chameleonData.photos); </script></div>
<p class="story-body-text" itemprop="articleBody">Internal SAC trading records, according to people directly involved in the case, indicate that the hedge fund did not have a negative bet in place in advance of the announcement of the drug trialâs disappointing results. Instead, the records indicated that SAC, through a series of trades, including a complex transaction known as an equity swap, had virtually no exposure â neither long nor short â heading into the disclosure of the drug data.</p>
<p class="story-body-text" itemprop="articleBody">A different narrative surrounding the firmâs trading could help Mr. Martoma, who has pleaded not guilty to securities fraud and conspiracy in what the government calls the most lucrative insider trading case ever charged.</p>
<p class="story-body-text" itemprop="articleBody">The government, however, does have powerful evidence against Mr. Martoma. Prosecutors say the fund avoided losses by selling its roughly $700 million stake in Elan and Wyeth. If, as the government says, Mr. Martoma caused SAC to sell the shares â and then short them â while possessing important, nonpublic information, that would constitute an insider trading crime. And prosecutors have secured the testimony of the doctor who says he leaked the drug trial data to Mr. Martoma.</p>
<p class="story-body-text" itemprop="articleBody">Still, perhaps more important, the trading records may complicate a government effort to pursue a case against Mr. Cohen. The SAC founder has not been accused of any wrongdoing, and has said he acted appropriately at all times.</p>
<p class="story-body-text" itemprop="articleBody">In bringing charges against Mr. Martoma, prosecutors appeared to be circling nearer to Mr. Cohen. The criminal complaint against Mr. Martoma noted that Mr. Cohen had spent 20 minutes on the telephone with the portfolio manager the night before SAC began selling its shares. Prosecutors have not claimed that Mr. Cohen knew that Mr. Martoma had confidential information about the drug trials. (Mr. Martoma has refused so far to cooperate in helping the government build a case against his former boss.)</p>
<p class="story-body-text" itemprop="articleBody">Yet if the 2008 trade is a possible avenue for the government, it is running out of time to bring a case against Mr. Cohen. Under the statute of limitations for insider trading crimes, the government would have to file a criminal case against him by mid-July. That deadline is the five-year anniversary of the trade in question, unless it could prove a conspiracy with Mr. Martoma that continued well past then.</p>
<p class="story-body-text" itemprop="articleBody">Prosecutors have not sought to reach a âtolling agreementâ with Mr. Cohen, which would allow the government additional time to bring a case past the statute of limitations, according to people briefed on the matter. The S.E.C., meanwhile, is weighing whether to file a civil fraud lawsuit against the fund connected to the drug-stock trades.</p>
<p class="story-body-text" itemprop="articleBody">All this comes as a Feb. 14 cutoff approaches for SAC clients to ask for their money back. The fund has told employees that it expects at least $1 billion in withdrawals from the $14 billion fund amid the intensifying investigation. SAC has a standard quarterly redemption deadline.</p>
<p class="story-body-text" itemprop="articleBody">Several other factors could make it difficult for the government to implicate Mr. Cohen. SAC is well known for its aggressive, rapid-fire trading style, and several former employees say that there is nothing unusual about the fundâs exiting a large position over just a few days.</p>
<p class="story-body-text" itemprop="articleBody">âItâs one thing to bring an insider trading charge against a market novice who pours his 401(k) into a stock after hanging up the phone with an insider,â said Morris J. Fodeman, a former prosecutor and now a white-collar criminal defense lawyer at Wilson Sonsini Goodrich &#038; Rosati. âBut itâs far more difficult to make a case against a sophisticated hedge fund that routinely takes large positions and employs complex trading strategies.â</p>
<p class="story-body-text" itemprop="articleBody">Moreover, both inside and outside SAC, there had been much controversy and debate surrounding the effectiveness of the Alzheimerâs drug, called bapineuzumab, leading up to the July 2008 release of the companiesâ clinical results. Mr. Martomaâs colleagues in SACâs health care group raised specific concerns with Mr. Cohen about the wisdom of holding such a large position in the two companies. And while preliminary data announced by Elan and Wyeth in June offered encouraging news, they also suggested potential problems.</p>
<p class="story-body-text" itemprop="articleBody">âWe believe potentially confounding factors will continue to fuel controversy over bapineuzumab,â wrote Caroline Y. Stewart, a drug stock analyst with Piper Jaffray, reacting to the preliminary results.</p>
<p class="story-body-text" itemprop="articleBody">On July 11, another Wall Street analyst, Jonathan Aschoff at Brean Murray Carret &#038; Company, raised red flags about a sharp run-up in the price of Elanâs shares heading into the presentation of the data.</p>
<p class="story-body-text" itemprop="articleBody">âWe have numerous concerns with the clinical development of bapineuzumab, and what we viewed to be underwhelming top-line Phase 2 results make us highly doubtful of success,â Mr. Aschoff wrote. âIn our opinion, this strategy only serves to increase clinical risk and stoke our pessimism.â</p>
<p class="story-body-text" itemprop="articleBody">The uncertainty relating to the Alzheimer drugâs clinical results could help explain what led Mr. Cohen to hedge SACâs position so that it had âneutral exposure,â in Wall Street parlance, heading into disclosure of the trial results.</p>
<p class="story-body-text" itemprop="articleBody">The short positions that SAC established in Elan and Wyeth were matched almost perfectly to offset an equity swap that effectively provided the fund with exposure to 12 million Wyeth shares, according to the SAC documents. An equity swap mimics ordinary shares and gives investors like hedge funds the benefits of stock ownership without actually owning the shares. Funds often use these complex derivatives to accumulate a large position but not tip off the market.</p>
<p class="story-body-text" itemprop="articleBody">When government officials announced the case against Mr. Martoma, they made no mention of the swap. Instead, they emphasized how SAC had jettisoned its Elan and Wyeth shares and then brazenly accumulated short positions in both companies.</p>
<p class="story-body-text" itemprop="articleBody">âThe charges unsealed today describe cheating â coming and going,â <a href="//topics.nytimes.com/top/reference/timestopics/people/b/preet_bharara/index.html?inline=nyt-per" class="tickerized" title="More articles about Preet Bharara.">Preet Bharara</a>, the United States attorney in Manhattan, said in opening remarks during the press conference. âSpecifically, insider trading first on the long side, and then on the short side.â</p>
<p class="story-body-text" itemprop="articleBody">The government noted the swap position in its court papers, but did not factor it into SACâs overall gains and losses in Elan and Wyeth. Because SAC did not trade the Wyeth swap, instead leaving the position in place, it could not be part of any insider trading charge.</p>
<p class="story-body-text" itemprop="articleBody">Representatives for the United States attorneyâs office and the S.E.C. declined to comment. An SAC spokesman declined to comment, as did Charles A. Stillman, the lawyer for Mr. Martoma.</p>
<p class="story-body-text" itemprop="articleBody">Prosecutors have built their case against Mr. Martoma by securing the cooperation of Dr. Sidney Gilman, a neurology professor who ostensibly leaked to him the confidential data about the drug being jointly developed by Elan and Wyeth. The companies hired Dr. Gilman to oversee the clinical trials. SAC paid Dr. Gilman about $108,000 as a consultant.</p>
<p class="story-body-text" itemprop="articleBody">The government said that Mr. Cohenâs fund accumulated a roughly $700 million combined stake in Elan and Wyeth based on Mr. Martomaâs recommendation. SACâs equity swap with respect to Wyeth, however, added $566 million in exposure.</p>
<p class="story-body-text" itemprop="articleBody">On Thursday, July 17, 2008, as the drug trials neared completion, Dr. Gilman told Mr. Martoma that patients were experiencing serious side effects, the government said. Three days later, on a Sunday, with the markets closed, Mr. Martoma had the 20-minute conversation with Mr. Cohen, according to telephone records cited in the criminal complaint. Prosecutors said that Mr. Martoma told his boss that he was no longer âcomfortableâ with the investments.</p>
<p class="story-body-text" itemprop="articleBody">On Monday morning, July 21, at Mr. Cohenâs direction, SACâs head trader began selling the fundâs 10.5 million shares of Elan and 7.1 million shares of Wyeth. By July 29 â the day that the companies announced the trial results â SAC had not only sold out of its Elan and Wyeth holdings but also established short positions in the stocks. SAC was short about 4.5 million shares of Elan and 3.3 million shares of Wyeth. The fund also purchased a small number of Elan put options, a bet that the companyâs shares would decline.</p>
<p class="story-body-text" itemprop="articleBody">The 12 million-share equity swap position in Wyeth, however, counterbalanced the short exposure. SAC was short 4.5 million shares of Elan but, taking the swap into account, effectively long about 8.7 million shares of Wyeth. On July 30, the first trading day after the companies disclosed the negative trial results, Elanâs stock fell about 42 percent and Wyethâs stock dropped about 12 percent.</p>
<p class="story-body-text" itemprop="articleBody">Federal prosecutors said that SACâs trading ahead of the announcement allowed the fund to avoid $194 million in losses by exiting the Elan and Wyeth positions, and then also earn about $83 million on the short trades. But SAC also had paper losses of about $70 million on its Wyeth swap, almost entirely negating any gains from the short sales.</p>
<p class="story-body-text" itemprop="articleBody">While such details would seem to contradict how authorities have described the trading, prosecutors could argue that SAC had little choice but to leave the swaps in place, and that was part of the strategy to trade on inside information. That is because selling a swap would be difficult to do without attracting attention in the marketplace. If SAC had sold its swaps, it would have had to notify the Wall Street bank that it entered into the swap transaction with and, in turn, the bankâs trader would have most likely sold the shares on the open market.</p>
<footer class="story-footer">
    <div class="story-meta">
	<p class="story-print-citation">A version of this article appears in print on 02/04/2013, on page <span itemprop="printSection">B</span><span itemprop="printPage">1</span> of the <span itemprop="printEdition">NewYork</span> edition with the headline: New Details Suggest A Defense In SAC Case.</p>    </div>
</footer>
	</div>
		<footer class="entry-footer">
			<button class="button comments-button theme-speech-bubble"></button>		<div id="sharetools-post-footer" class="sharetools theme-classic" data-shares="show-all|Share" data-url="https://dealbook.nytimes.com/2013/02/03/new-details-suggest-a-defense-in-sac-case/" data-title="New Details Suggest a Defense in SAC Case" data-description="Internal trading records also raise questions on whether the government will be able to build a case against Steven A. Cohen, the billionaire owner of the hedge fund. ">
				<div class="ad sharetools-inline-article-ad hidden"></div>
			</div>		<div class="footer-tags">
					</div>
		</footer>
</article>
		<section id="whats-next" class="whats-next nocontent robots-nocontent">
    <h2 class="visually-hidden">What's Next</h2>
    <div class="nocontent robots-nocontent">
        <div class="loader-container">
            <div class="loader loader-t-logo-32x32-ecedeb-ffffff"><span class="visually-hidden">Loading...</span></div>
        </div>
    </div><!-- close nocontent -->
</section>

			</div><!-- end content -->
</div><!-- end .a-column -->
<div class="cColumn nocontent robots-nocontent">
	<aside>
	<div class="postNavigation">
	<ul class="opposingFloatControl wrap">
		<li class="element1">
						<span class="previous">Previous Post</span>
			<div class="arrow arrow-left">
				<div class="arrow-conceal"></div>
			</div>
			<a class="postTitle" href="https://dealbook.nytimes.com/2013/02/03/barclays-c-f-o-to-step-down/" title="2 Top Officers at Barclays to Step Down">
				2 Top Officers at Barclays to Step Down			</a>
					</li>
		<li class="element2">
						<span class="next">Next Post</span>
			<div class="arrow arrow-right">
				<div class="arrow-conceal"></div>
			</div>
			<a class="postTitle" href="https://dealbook.nytimes.com/2013/02/04/citigroup-appoints-senior-banker-in-europe/" title="Citigroup Names Senior Banker in Europe">
				Citigroup Names Senior Banker in Europe			</a>
					</li>
	</ul>
</div>
		<div class="module ad" id="MiddleRight"></div>
        	</aside>
</div>		<div class="clear"></div>
	</div><!-- end blog wrap -->
	<div class="hideContent"></div>

	
<!-- Google Analytics start -->
<script type="text/javascript">
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){ (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o), m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;if (!/NYT-T=out/.test(document.cookie)) {m.parentNode.insertBefore(a,m)} })(window,document,'script','//www.google-analytics.com/analytics.js','ga');
ga('create', 'UA-4406282-12',  { 'alwaysSendReferrer': true } );
ga('send', 'pageview');
</script>
<!-- Google Analytics end -->
		<div id="mobilebanner2" class="ad mobilebanner2"></div>
		<div class="accessibility-ad-header visually-hidden">
    <p>Advertisement</p>
</div>
<div id="SponLink" class="text-ad bottom-left-ad nocontent robots-nocontent"></div>

		<div id="Top5" class="ad top5-ad hidden nocontent robots-nocontent"></div>

					</div>
			<div class="search-overlay"></div>
		</main><!-- close main -->
						<footer id="page-footer" class="page-footer" role="contentinfo">
    <nav>
         <ul>
             <li>
                <a href="https://www.nytco.com" itemprop="copyrightNotice">
                    &copy; <span itemprop="copyrightYear">2017</span>
					<span itemprop="copyrightHolder provider sourceOrganization" itemscope
						itemtype="//schema.org/Organization"
						itemid="//www.nytimes.com">
						<span itemprop="name"> The New York Times Company</span>
						<meta itemprop="tickerSymbol" content="NYSE NYT"/>
					</span>
                </a>
            </li>
            <li><a href="https://www.nytimes.com/ref/membercenter/help/infoservdirectory.html">Contact Us</a></li>
            <li><a href="//www.nytco.com/careers/">Work With Us</a></li>
            <li><a href="//nytmediakit.com/">Advertise</a></li>
            <li><a href="https://www.nytimes.com/content/help/rights/privacy/policy/privacy-policy.html#pp">Your Ad Choices</a></li>
            <li><a href="https://www.nytimes.com/privacy">Privacy</a></li>
            <li><a href="https://www.nytimes.com/ref/membercenter/help/agree.html" itemprop="usageTerms">Terms of Service</a></li>
            <li class="last-item"><a href="https://www.nytimes.com/content/help/rights/sale/terms-of-sale.html">Terms of Sale</a></li>
         </ul>
    </nav>
    <nav class="last-nav">
        <ul>
            <li><a href="//spiderbites.nytimes.com">Site Map</a></li>
            <li><a href="https://www.nytimes.com/membercenter/sitehelp.html">Help</a></li>
            <li><a href="https://myaccount.nytimes.com/membercenter/feedback.html">Site Feedback</a></li>
            <li class="last-item"><a href="https://www.nytimes.com/subscriptions/Multiproduct/lp5558.html?campaignId=37WXW">Subscriptions</a></li>
        </ul>
    </nav>
</footer>		</div><!-- close shell -->
	<script>
require(['foundation/main'], function () {
    require(['blogs/main']);
    require(['jquery/nyt', 'foundation/views/page-manager'], function ($, pageManager) {
        if (window.location.search.indexOf('disable_tagx') > 0) {
            return;
        }
        $(document).ready(function () {
            require(['https://a1.nyt.com/analytics/json-kidd.min.js'], function () {
                pageManager.trackingFireEventQueue();
            });
        });
    });
});
</script>

	<div id="Inv1" class="ad inv1-ad hidden"></div>
<div id="Inv2" class="ad inv2-ad hidden"></div>
<div id="Inv3" class="ad inv3-ad hidden"></div>
<div id="ab1" class="ad ab1-ad hidden"></div>
<div id="ab2" class="ad ab2-ad hidden"></div>
<div id="ab3" class="ad ab3-ad hidden"></div>
<div id="prop1" class="ad prop1-ad hidden"></div>
<div id="prop2" class="ad prop2-ad hidden"></div>
<div id="Anchor" class="ad anchor-ad hidden"></div>
<div id="ADX_CLIENTSIDE" class="ad adx-clientside-ad hidden"></div>
		<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","licenseKey":"b5bcf2eba4","applicationID":"5164608","transactionName":"YwFXZhRYVhAEVUZcX1pLYEAPFlkTFRtQWV9TFxtCDkk=","queueTime":0,"applicationTime":46,"ttGuid":"","agentToken":"","userAttributes":"","errorBeacon":"bam.nr-data.net","agent":""}</script></body>
</html>
